Drug Development Associates, LLC
Diane Paul, MS, RN is currently the Chief Operating Officer of Drug Development Associates, LLC, a clinical development and regulatory strategy company that assists emerging biotechnical and pharmaceutical companies. Ms. Paul has extensive experience and a strong background in pharmaceutical and academic research. She is a graduate of Rutgers University where she received a Master of Science degree in Psychiatric/Mental Health Nursing.
.
This course provides an expansive review of human subjects research topics for biomedical researchers.
This course provides an expansive review of human subjects research topics for social-behavioral-educational researchers.
This course provides retraining on the HSR Biomed Basic course and discusses core human subjects research topics for biomedical...
This course provides retraining on the HSR Biomed Basic course and discusses core human subjects research topics for biomedical...
This course provides retraining on the HSR Biomed Basic course and discusses core human subjects research topics for biomedical...
Provides foundational training for IRB members involved in the review of biomedical human subjects research.
Provides foundational training for IRB members involved in review of social-behavioral-educational human subjects research.
Provides foundational training for IRB members involved in the review of both biomedical and social-behavioral-educational huma...
This course provides advanced learners all the CIP approved modules on topics such as informed consent, U.S. Food and Drug Admi...
This course provides advanced learners a topic-focused course on biomedical and U.S. Food and Drug Administration (FDA) researc...
This course provides advanced learners a topic-focused course on subject population and informed consent topics as well as 9 CE...
This course provides training for research personnel involved in clinical investigations of devices.
Ideal for individuals proposing to conduct clinical trials of drugs, biologics, and devices primarily in the U.S.
Ideal for individuals proposing to conduct clinical trials of drugs and biologics in the U.S. or internationally.
Covers regulatory inspections of clinical investigators and sites, including mock inspections, 482s, 483s, warning letters, communication, and CAPA plans.